170 related articles for article (PubMed ID: 11757558)
1. Listed chemicals; establishment of non-regulated transactions in anhydrous hydrogen chloride. Final rule confirmation.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2001 Aug; 66(159):42944-6. PubMed ID: 11757558
[TBL] [Abstract][Full Text] [Related]
2. Exemption of chemical mixtures. Final rule.
Drug Enforcement Administration (DEA), U.S. Department of Justice
Fed Regist; 2007 Mar; 72(47):10925-8. PubMed ID: 17450656
[TBL] [Abstract][Full Text] [Related]
3. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 Jun; 68(121):37411-4. PubMed ID: 12836650
[TBL] [Abstract][Full Text] [Related]
4. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
[TBL] [Abstract][Full Text] [Related]
5. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2008 Jul; 73(133):39611-4. PubMed ID: 18850676
[TBL] [Abstract][Full Text] [Related]
6. Implementation of the Methamphetamine Anti-Proliferation Act; thresholds for retailers and for distributors required to submit mail order reports; changes to mail order reporting requirements. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 Oct; 68(194):57799-804. PubMed ID: 14535265
[TBL] [Abstract][Full Text] [Related]
7. Removal of thresholds for the List I chemicals pseudoephedrine and phenylpropanolamine. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2010 Jul; 75(129):38915-22. PubMed ID: 20608288
[TBL] [Abstract][Full Text] [Related]
8. Retail sales of scheduled listed chemical products; self-certification of regulated sellers of scheduled listed chemical products. Interim final rule with request for comment.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2006 Sep; 71(186):56008-27. PubMed ID: 17017470
[TBL] [Abstract][Full Text] [Related]
9. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2011 Dec; 76(231):74696-9. PubMed ID: 22145189
[TBL] [Abstract][Full Text] [Related]
10. Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 May; 68(84):23195-206. PubMed ID: 12725239
[TBL] [Abstract][Full Text] [Related]
11. Special surveillance list of chemicals, products, materials and equipment used in the clandestine production of controlled substances or listed chemicals. Drug Enforcement Administration (DEA), Justice. Final notice.
Fed Regist; 1999 May; 64(92):25910-2. PubMed ID: 10558537
[TBL] [Abstract][Full Text] [Related]
12. Changes in the regulation of iodine crystals and chemical mixtures containing over 2.2 percent iodine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2007 Jul; 72(126):35920-31. PubMed ID: 17910137
[TBL] [Abstract][Full Text] [Related]
13. Medicaid program; time limitation on record keeping requirements under the drug rebate program. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2004 Jan; 69(3):508-14. PubMed ID: 14968795
[TBL] [Abstract][Full Text] [Related]
14. Exempt chemical mixtures containing gamma-butyrolactone. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Jun; 75(124):37301-7. PubMed ID: 20608286
[TBL] [Abstract][Full Text] [Related]
15. Registration and reregistration application fees. Confirmation of final rule, remanded for further notice and comment, and response to comments.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2002 Aug; 67(154):51987-52007. PubMed ID: 12194173
[TBL] [Abstract][Full Text] [Related]
16. Registration and reregistration application fees. Final rule; remanded for further notice and comment.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 1996 Dec; 61(251):68624-6. PubMed ID: 12192680
[TBL] [Abstract][Full Text] [Related]
17. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Interim rule with request for comments.
Drug Enforcement Administration (DEA), U.S. Department of Justice
Fed Regist; 2007 Apr; 72(77):20039-47. PubMed ID: 17520757
[TBL] [Abstract][Full Text] [Related]
18. Import and production quotas for certain List I chemicals. Interim final rule with request for comment.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2007 Jul; 72(131):37439-53. PubMed ID: 17674492
[TBL] [Abstract][Full Text] [Related]
19. Designation of Alpha-Phenylacetoacetonitrile (APAAN), a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Jul; 82(134):32457-61. PubMed ID: 28715162
[TBL] [Abstract][Full Text] [Related]
20. Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2008 May; 73(100):29685-8. PubMed ID: 18605404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
